Organon And Co 's Revenue in the fiscal year 2025 $ 6,216.00 millions
Organon And Co 's Revenue in the fiscal year 2024 $ 6,403.00 millions
Organon And Co 's Revenue in the fiscal year 2023 $ 6,263.00 millions
Organon And Co 's Revenue in the fiscal year 2022 $ 6,174.00 millions
Organon And Co 's Revenue in the fiscal year 2021 $ 6,304.00 millions
OGN Revenue third quarter 2026 Y/Y Growth Comment
Organon And Co reported decrease in Revenue in the third quarter 2026 by -1.75% to $ 1,574.00 millions, from the same quarter in 2025. The decrease in the third quarter 2026 Organon And Co 's Revenue compares unfavorably to the Company's average Revenue decrease of -1.01%.
Looking into third quarter 2026 results within Major Pharmaceutical Preparations industry 140 other companies have achieved higher Revenue growth. While Organon And Co ' s Revenue decline of -1.75% ranks overall at the positon no. 3007 in the third quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Organon And Co 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
6.71 %
-0.41 %
-14.27 %
(Jun 30 2026)
OGN's III. Quarter Q/Q Revenue Comment
Organon and Co achieved in the III. Quarter 2026 above company average sequential Revenue growth of 1.03%, to $ 1,574.00 millions, from $1,558.00 millions in the second quarter.
Within Major Pharmaceutical Preparations industry 63 other companies have achieved higher Revenue quarter on quarter growth. While Organon And Co 's Revenue growth quarter on quarter, overall rank is 1030.
Organon and Co achieved in the III. Quarter 2026 above company average sequential Revenue growth of 1.03%, to $ 1,574.00 millions, from $1,558.00 millions in the second quarter.
Within Major Pharmaceutical Preparations industry 63 other companies have achieved higher Revenue quarter on quarter growth. While Organon And Co 's Revenue growth quarter on quarter, overall rank is 1030.
Organon And Co 's 12 Months Revenue Growth Year on Year
Organon And Co 's cumulative 12 months Revenue continue to decrease, but on the faster rate at -3.02% year on year, at Sep 30 2026 compare to the -2.26% decrease at Jun 30 2026. If the Organon And Co 's fiscal year would end at Sep 30 2026, annual Revenue would be $6,111 millions.
In the Healthcare sector 365 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 858 to 2534.
Organon And Co 's cumulative 12 months Revenue continue to decrease, but on the faster rate at -3.02% year on year, at Sep 30 2026 compare to the -2.26% decrease at Jun 30 2026. If the Organon And Co 's fiscal year would end at Sep 30 2026, annual Revenue would be $6,111 millions.
In the Healthcare sector 365 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 858 to 2534.
About Organon And Co Revenue Growth Rates (OGN), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
